Quan P. Ly, M.D., F.A.C.S.

PERSONAL DATA

Office Address: University of Nebraska Medical Center

Department of Surgery 986880 Nebraska Medical Center Omaha, NE 68198-6880 Work: (402) 559-8941 Fax: (402) 559-7900 Email: qly@unmc.edu

EDUCATION

September 1988 – June 1992 University of California at Davis, Davis, CA BS, Animal Physiology BA, Chemistry

Minor: Psychology

August 1992 – June 1996 Albert Einstein College of Medicine, Bronx, NY MD

POSTDOCTORAL TRAINING

June 1996 – June 1997 General Surgery Internship

Medical College of Pennsylvania and Hahnemann University Hospitals, Philadelphia, PA

July 1997 – June 2002 General Surgery Residency

Medical College of Pennsylvania and Hahnemann University Hospitals, Philadelphia, PA

July 1998 – June 2000 Post-doctoral Scholar

Medical College of Pennsylvania and Hahnemann University Hospitals, Philadelphia, PA

July 2002 – June 2003 General Surgery Chief Resident

Medical College of Pennsylvania and Hahnemann University Hospitals, Philadelphia, PA

July 2003 – June 2005 Surgical Oncology Fellowship

H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL

July 2005 – June 2006 Surgical Oncology Research Fellowship H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL

Quan Ly, MD – CV (6/2019) Page 2

ADVANCED COURSES

October 3, 2003 Sentinel Node Biopsy Course

Certificate of completion given by the H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.

October 15, 2005 Career Development Course

One-day seminar and lecture about planning an academic surgical career, finding a mentor, grant-writing, getting promoted, balancing research, clinical and family life. Given by the Association of Academic

Surgeons. San Francisco, CA.

August 11, 2006 Laparoscopic Colon Resection

Certificate of completion given by University of Nebraska Medical Center, Omaha, NE.

July 11-18, 2008 Molecular Biology in Clinical Oncology: Workshop

An Intensive Workshop on the Latest Developments in Molecular Biology Relevant to Clinical Oncologists Pursuing the Desire to Bridge the Gap as Physician-Scientists. University of Colorado. Sponsored by the American

Association of Cancer Research. Aspen, CO.

March 5-7, 2010 Surgical Investigators Conference Intense course to familiarize new surgical faculty with grant writing skills, expose surgeon-scientists to the process, content, style of successful grant writing, and interaction with National Institute of Health scientists.

Sponsored by the American College of Surgeons. North Bethesda, MD.

March 29, 2012 Fundamental of Laparoscopic Surgery

Certificate of completion given by University of Nebraska Medical Center, Omaha, NE.

March 18, 2016 NanoKnife Training Course

Louisville, KY.

December 1, 2017 Responsible Conduct in Research (RCR) Training

University of Nebraska Medical Center, Omaha, NE.

January 24, 2018 Zero Harm Trainer Course

Nebraska Medicine, Omaha, NE.

February 28, 2018 Zero Harm Trainer Certification Nebraska Medicine, Omaha, NE.

ACADEDMIC APPOINTMENTS

July 2017 – present Medical Director for GI Oncology

University of Nebraska Medical Center, Omaha, NE

July 2017 – present Medical Director for Werner, 6th floor Progressive Care Unit

University of Nebraska Medical Center, Omaha, NE

Quan Ly, MD – CV (6/2019) Page 3

July 2015 – present Associate Professor of Surgery University of Nebraska Medical Center, Omaha, NE

August 2006 – present Associate Member, Fred & Pamela Buffett Cancer Center

University of Nebraska Medical Center, Omaha, NE

August 2006 – July 2015 Assistant Professor of Surgery

University of Nebraska Medical Center, Omaha, NE

PROFESSIONAL LICENSES AND CERTIFICATIONS

08/1998 – 06/2006 State Medical License, Pennsylvania, MD-066689-L

12/2005 – 12/2026 American Board of Surgery Recertification, #050845

07/2006 – 10/2020 State Medical License, Nebraska, #23788

07/2006 – 03/2021 Federal Drug Enforcement Administration Certificate

10/2008 Fellow of the American College of Surgeons

03/2009 Society of Surgical Oncology Fellowship

GRANTS

Active:

Title: Validation of Biomarkers for Early Diagnosis and Risk Prediction of Pancreatic Neoplasms ID Number: 0058337 (132124-1) Funding Agency: University of Pittsburgh Project Period: 2016 – 2020 Total Dollars: $1,180,364 Direct Cost: $75,000 Role: Co-Investigator (Batra)

Title: SPORE in Pancreatic Cancer

ID Number: 5P50CA127297-10 Funding Agency: DHHS/NIH/NCI Project Period: 2014 - 2019 Total Dollars: $17,068,380 Direct Cost: $1,528,998 Role: Co-Investigator (Hollingsworth)

Sub-Project 2: Title: Novel Target(s) in treatment of Pancreatic Cancer ID Number: 5P50CA127297-10 Funding Agency: DHHS/NIH/NCI Project Period: 2018 - 2019 Total Dollars: $366,080 Direct Cost: $243,880 Role: Co-Investigator (Batra)

Quan Ly, MD – CV (6/2019) Page 4

Sub-Project 3: Title: Novel Strategies for Pancreatic Cancer Treatment

ID Number: 5P50CA127297-10 Funding Agency: DHHS/NIH/NCI Project Period: 2018-2019 Total Dollars: 367,221 Direct Cost: 243,879 Role: Co-Project Leader (Black)

Title: LB595 Tobacco Tax Center Research Grant ID Number: Funding Agency: NE DHHS - LB595 Project Period: 2015 - 2019 Total Dollars: $33,904,831 Direct Cost: $1,300,000 Role: Co-Investigator (Cowan) Pending:

Title: Near infrared fluorescent conjugates for surgical imaging of peritoneal cancers ID Number: Funding Agency: DHHS/NIH Project Period: 2019 - 2024 Total Dollars: $2,495,897 Direct Cost: $1,636,654 Role: Co-Investigator (Mohs) Title: Phenotypic and Functional Characterization of the Influence of the Tumor Microenvironment on

Immune Responses to Pancreatic Cancer ID Number: 1U01CA224184-01 Funding Agency: DHHS/NIH/NCI Project Period: 2017 - 2022 Total Dollars: $2,633,750 Direct Cost: $1,750,000 Role: Co-Investigator (Hollingsworth) Title: Image-guided therapy for local and advanced ovarian cancer ID Number: Funding Agency: NE DHHS - LB506 Project Period: 2018 - 2019 Total Dollars: $50,000 Direct Cost: $50,000 Role: Co-Investigator (Mohs) Title: SPORE in Pancreatic Cancer (Renewal)

Funding Agency: DHHS/NIH/NCI Project Period: 2020 - 2025 Direct Cost: $1,528,998 Role: Co-Investigator (Hollingsworth)

Quan Ly, MD – CV (6/2019) Page 5

Completed: Title: CCL21 Immunotherapy for Pancreatic Cancer ID Number: 2015-54 Funding Agency: NE DHHS - LB506 Project Period: 2014 - 2015 Total Dollars: $50,000 Direct Cost: $50,000 Role: Co-Investigator (Solheim)

Title: Early Diagnosis of Pancreatic Cancer Administrative Supplement ID Number: 155022 Funding Agency: University of Texas Health Science Center at San Antonio Project Period: 2012 - 2014 Total Dollars: $297,000 Direct Cost: $200,000 Role: Co-Investigator (Hollingsworth) Title: SPORE Career Development Program ID Number: 5P50CA127297-02 Funding Agency: NIH/NCI Project Period: 7/2008-8/2010 Total Dollars: $194,839 Direct Cost: Role: Principal Investigator Title: SPORE in Gastrointestinal Cancer ID Number: 5P50 CA127297-05 Funding Agency: NIH/NCI Project Period: 9/2008-8/2014 Total Dollars: $1,066,666 Direct Cost: $757,105 Role: Co-Investigator (Hollingsworth) Title: Novel strategies for pancreatic cancer treatment ID Number: Funding Agency: NE DHHS LB595 Project Period: 08/2011 – 07/2012 Total Dollars: 50,000 Direct Cost: Role: Principal Investigator

ACADEMIC/TEACHING

1. Mock Oral Exams for General Surgery Residents

Participated in the mock oral exams for University of Nebraska Medical Center and Creighton General Surgery residents:

May 2007; May 2008; May 2009; May 2010; May 2011; May 2013; May 2014; May 2015; May 2016; April 2018; October 2018.

Quan Ly, MD – CV (6/2019) Page 6

2. Surgical Resident Seminars and Case Conference: 2–hour session; 2-3 times a year. Review residents’ slides and moderate discussion of basic physiology or molecular biology as well as clinical case presentation: Stomach, breast, molecular oncology and colon. Time: 4–5 hours/year

3. Advanced Anatomy (Cadaver Labs) for Surgical Residents (2010 – present)

Prepared course syllabus and exams for several of the procedures. The components of the curriculum: Simulate OR experience with the use of lightly embalmed cadavers and surgical instruments but without the stress of OR/patient costs. Provide opportunity for the residents to practice surgical procedures or techniques under close guidance. Time: 2-hour sessions, 5–6 times a year

4. Orientation of New Interns to General Surgery (June 2012 & 2013)

Prepare lectures, demonstrate techniques and provide opportunity for the residents to learn basic surgical skills, such as central line placement, chest tube placement, airway management, suture material, suturing, and knot tying. Time: 4-hours session, 2-4 sessions each year, 8–16 hours/year

5. ABSITE Individual Mentoring (July 2009 – 2016)

We meet weekly to biweekly to DISCUSS and REVIEW surgical topics or systems to improve the residents’ fund of knowledge. I also advise and mentor the female residents on work-life balance. Time: 40 hours/year

6. Medical Student Skill Labs (July 2014 – July 2015)

Design and develop techniques to teach medical students basic surgical skills, such as suturing and knot tying, chest tube placement, and laparoscopic fundamentals. Time: 2-hour session; 3 times per rotation. 6 rotations/year

7. Mentor 3rd year medical students during surgery rotation (Jan 2008 – 2013)

Advise and prepare 3rd year medical students for their surgical rotation in presentation skills, problem solving, and practice for oral exams. Time: 1-hour sessions/week; 7-8 week each rotation, 2-3 groups/year. 22 hours/year

8. Zero Harm Training Courses:

July 25, 2018 August 8, 2018 August 22, 2018 August 25, 2018 September 4, 2018 September 22, 2018 November 28, 2018

HONORS & AWARDS

09/1991 – 06/1992 College of Agriculture and Environment Scholarship 03/1996 The Irving M. Ratner, MD Award, Outstanding Performance in the Field of

Pathology, University of California at Davis 05/2003 Alpha Omega Alpha, Medical College of Pennsylvania & Hahnemann University 07/2014 Outstanding Teaching Award, University of Nebraska Medical Center, Department

of Surgery

Quan Ly, MD – CV (6/2019) Page 7

MEMBERSHIPS AND OFFICES IN PROFESSIONAL SOCIETIES

2005 – present American Society of Clinical Oncology 2006 – 2014 Southwestern Surgical Congress (Fellow) 2007 – present Association of Academic Surgery 2007 – present Nebraska Oncology Society 2007 – present Metro Omaha Medical Society/Nebraska Medical Association 2007 – present American College of Surgeons (Fellow) 2008 – present Society of Surgical Oncology 2010 – present American Medical Women’s Association 2014 – present Americas Hepato-Pancreato-Biliary Association (AHPBA) 2014 – present The Pancreas Club 2016 – present International Hepato-Pancreato-Biliary Association (IHPBA)

COMMITTEE ASSIGNMENTS University of Nebraska Medical Center 2006 – present Multidisciplinary GI Tumor Board

Member, August 2006 – present Director, December 2013 – present

2015 – present Cancer Committee Cancer Liaison Physician, December 2015 – December 2018 Vice Chair, 2015-present

Chair: Rudy Lackner, MD 2015 – present GI/Pancreas/Esophageal Working Group Member 2015 – present Strategic Planning Working Group Member 2015 – present Melanoma/Sarcoma Working Group Member

College of Medicine 2013 – 2016 CME Committee Member, 2013 – October 2016

Chair: Wesley Zeger, DO Department of Surgery 2010 – 2018 Journal Club for the Division of Surgical Oncology, Director 2010 & 2015 Promotion and Tenure Committee Member

Chair: Rudy Lackner, MD (2010); P.J. Schenarts, MD (2015) 2013 – 2014 Surgical Oncology Division Chief Search Committee

2013 – present Resident Clinical Competence Committee, September 2013-present

Chair: Jon Thompson, MD 2015 – 2015 Academic Variable Compensation Committee Member, October & November

Chair: Kim Schenarts, MD Fred and Pamela Buffett Cancer Center 2007 – present Scientific Review Committee, August 2007 – present

Chair: Greg Bociek, MD 2016 – 2016 iCaRe2 Investigators Committee, PI for a collaborative Pancreatic Cancer

Registry Member Chair: Whitney Goldner, MD

Quan Ly, MD – CV (6/2019) Page 8

Nebraska Medicine 2013 – 2018 Clinical Enterprise Physician Advisory Team Member

Veterans Affairs 2014 – 2018 Cancer Committee Member, May 2014 – 2018

Chair: Apar Ganti, MD

National 2010 – present National Cancer Center Network for Esophageal Panel Member

Chair: Jaffer Ajani, MD 2010 – present National Cancer Center Network for Gastric Cancers Panel Member

Chair: Jaffer Ajani, MD 2012 – 2014 Association of Academic Surgeons

Issue Committee Member, January 2012 – 2014 2012 – 2014 Society of Surgical Oncology

Membership Committee Member, March 2012 – 2014 2016 – present Americas Hepato-Pancreato-Biliary Association Research Committee Member

Chair: John Mansour, MD 2019 – present Americas Hepato-Pancreato-Biliary Association Program Committee Member

Chair: Felipe Coimbra, MD

PRESENTATIONS

1. Ly Q, Ho G, Tate D, Klein S, Drouart A, Winiarsky R, Cajigas A, Romney S, Steinberg JJ. Immunocytochemical (cytokeratin and Ki-67) and DNA adduct analyses of human cervical lavage samples: Preliminary biomarkers of chemoprevention. Poster presented at the 85th Annual Meeting of American Association for Cancer Research. April 10-13, 1994. San Francisco,

CA.

2. Winiarsky R, Ly Q, Drouart A, Steinberg JJ, et al. Proliferation (BUDR & Ki-67) indices, and immunocytochemistry (vimentin) as biomarkers of therapeutic response by osteosarcoma cells. Poster presented at the 85th Annual Meeting of American Association for Cancer Research. April 10-13, 1994. San Francisco, CA.

3. Ly Q, Krishnaswami S, Rothman VL, Tuszynski GP. Thrombospondin-1 (TSP-1) Potentiates Fibroblast Activities Important in Wound Healing. Poster presentation at the 39th Annual Meeting for the American Society for Cell Biology. December 13, 1999. Washington, DC.

4. Ly Q, Cox C, White L, Dupont E, Cantor A, Reintgen DS, Dessureault S. Axillary recurrence after negative sentinel lymph node biopsy in breast cancer patients. Poster discussion at the 28th Annual San Antonio Breast Cancer Symposium. December 9, 2005. San Antonio, TX.

5. Ly Q, McCarthy S, Gruidl M, Yeatman, TJ. NBL1: A novel hypermethylation target in colon

cancer. Oral Presentation at the 59th Annual Meeting of the Society of Surgical Oncology. March 25, 2006. San Diego, CA.

6. Ly Q, Siegel E, McLoughlin J, Lewis J, Nair R, Jensen E, Alvarado M, Eschrich S, Yeatman TJ,

and Shibata D. NBL1 and Colon Cancer: Clinical and Genetic Associations. Poster presentation at the 60th Annual Meeting of the Society of Surgical Oncology. March 17, 2007.

Washington, DC.

Quan Ly, MD – CV (6/2019) Page 9

7. McLoughlin JM, Jensen EH, Alvarado M, Siegel E, Ly Q, Lewis JM, Nair RM, Eschrich S, Helm J, Yeatman TJ, and Shibata D. A Clinicogenomic Analysis of Right and Left-Sided Colon Cancers. Poster presentation at the 60th Annual Meeting of the Society of Surgical Oncology. March

17, 2007. Washington DC.

8. Meredith K, Siegel E, McLoughlin J, Nair R, Lewis J, Eschrich S, Bloom G, Ly Q, Jensen E, Alvarado M, Yeatman TJ, and Shibata D. Clinicogenomic Characterization Of Primary Colorectal Carcinoma Associated With Liver Metastases. Oral presentation at the 7th Annual Meeting of Americas Hepato-Pancreato-Biliary Association. April 22, 2007. Las Vegas, NV.

9. Meredith K, Siegel E, Sarnaik A, Alvarado M, Eschrich S, McLoughlin J, Nair R, Ly Q, Lewis J, Jensen E, Yeatman TJ, and Shibata D. Gene Expression Profiles and Recurrence in Stage II Colon Cancer. Plenary Presentation at the Annual Meeting of the American Society of Colon and Rectal Surgeons. June 4, 2007. St. Louis, MO.

10. Melis M, Ly Q, Nair R, Siegel E, McLoughlin J, Lewis J, Jensen E, Alvarado M, Eschrich S, Bloom

G, Yeatman TJ, and Shibata D. Colorectal Mucinous Adenocarcinomas Are Characterized By Markers of Differentiation and Components of the Mucin-Producing Machinery. Plenary presentation at the Annual Meeting of the American Society of Colon and Rectal Surgeons.

June 5, 2007. St. Louis, MO.

11. Ly QP. Establishment of Primary Cell Cultures from Surgically Resected Specimen. Presented at University of Nebraska Medical Center Pancreatic SPORE Annual Retreat. March 2009.

Omaha, NE.

12. Sasson A, Are C, Lazenby A, Ly Q. Comprehensive Pathologic Assessment of Pancreaticoduodenectomy Specimens. Poster presentation at the 63rd Annual Meeting of the Society of Surgical Oncology. March 3-7, 2010. St. Louis, MO.

13. Sasson A, Are C, Ly Q. Role of Laparoscopy in Neo-Adjuvant Therapy for Pancreatic Adenocarcinoma. Poster presentation at the 63rd Annual meeting of the Society of Surgical Oncology. March 3-7, 2010. St. Louis, MO.

14. Sasson A, Kim E, Ly Q, Are C. The benefit of intra-operative ultrasound in the management of suspected gallbladder cancer. Poster presentation at the Joint Meeting of the Americas Hepato-Pancreato-Biliary Association /International Hepato-Pancreato-Biliary Association. 2010.

Argentina.

15. Shah B, Ullrich F, Leiphrakpam P, Ly Q, Sasson A, Are C. National trends in discharge disposition following hepatic resection for malignancy. Poster presentation at the Joint Meeting of the Americas Hepato-Pancreato-Biliary Association /International Hepato-Pancreato-Biliary Association. 2010. Argentina.

16. Vargas L, Kim E, Ly Q, Are C, Sasson A. Incidental pancreatic adenocarcinoma: lack of

symptoms does not improve resectability rate. Poster presentation at the Joint Meeting of the Americas Hepato-Pancreato-Biliary Association /International Hepato-Pancreato-Biliary Association. 2010. Argentina.

17. Dhir M, Smith L, Ullrich F, Leiphrakpam P, Ly Q, Sasson A, Are C. Pre-operative nomogram to

predict risk of peri-operative mortality following hepatic resection for malignancy. Poster presentation at the 51st Annual Meeting of the Society of Surgery for Alimentary Tract. 2010.

New Orleans, LA.

Quan Ly, MD – CV (6/2019) Page 10

18. Lackner R, Trujillo K, Ly Q, Are C, Oleynikov D, Sasson A. Minimally invasive esophagectomy-

increasing the surgical options for esophageal cancer. Poster presentation at the 62nd Annual Meeting of the Southwestern Surgical Congress; April 2010. Tucson, AZ.

19. Ly QP, Chaika N, Lele S, Lazenby A, Are C, Sasson, AR, Johnson K. In Pancreatic Cancer,

Metastatic Tissue Has Decreased hENT1 Expression Than Primary Tumor. Poster presentation at the 64th Annual Meeting of the Society of Surgical Oncology. March 2-5, 2011. San Antonio, TX.

20. Shah B, Smith L, Ullrich F, Ly Q, Sasson A, Are C. National trends in discharge disposition

following pancreatic resections for malignancy. Poster presentation at the Americas Hepato-Pancreato-Biliary Association. March 2011. Miami, FL.

21. Malhotra G, Smith L, Ly Q, Sasson A, Are C. National trends in survival for pancreatic

adenocarcinoma based on location of the primary lesion. Plenary presentation at the 52nd Annual Meeting of the Society of Surgery for Alimentary Tract, May 6-10, 2011. Chicago, IL.

22. Malhotra G, Smith L, Ly Q, Sasson A, Are C. National trends in the incidence and stage of

disease at initial presentation for patients with pancreatic adenocarcinoma. Poster presentation at the 52nd Annual Meeting of the Society of Surgery for Alimentary Tract, May 6-10, 2011. Chicago, IL.

23. Dhir M, Smith L, Ullrich F, Ly Q, Sasson A, Are C. Pre-operative nomogram to predict risk of peri-

operative mortality following gastric resection for malignancy. Poster presentation at the 52nd Annual Meeting of the Society of Surgery for Alimentary Tract, May 6-10, 2011. Chicago, IL.

24. Worth J, Trujillo KP, Grem JL, Ly QP, Are C, Sasson AR, Lackner RP. Role of Operative

Resection for Colorectal Pulmonary Metastases. Oral presentation at the 63rd Annual Meeting of the Southwestern Surgical Congress, April 3-8, 2011. Ko Olina, HI.

25. Ly QP, Wang W, Person J, et al. YM155, a small molecule inhibitor of survivin, as a novel

therapy in the treatment of pancreatic cancer. Oral presentation at the 7th Academic Surgical Congress, February 15, 2012. Las Vegas, NV.

26. Ly QP, Person J, Brattain MG. Survivin is a potential new therapeutic target in the treatment of

pancreatic cancer. Poster presentation at the 65th Annual Meeting of the Society of Surgical Oncology, March 21-24, 2012. Orlando, FL.

27. Shah B, Smith LM, Sasson AR, Ly QP, Are C. National trends in surgical management of cystic

lesions of the pancreas. Poster presentation at the 65th Annual Meeting of the Society of Surgical Oncology, March 21-24, 2012. Orlando, FL.

28. Lin C, Lazenby AJ, Hussain SM, Sasson AR, Chen S, Ly QP, Schwarz JK, Kos ME, Are C, Grem

JL. Borderline resectable pancreatic adenocarcinoma: tumor volume and CA 19-9 reduction following neoadjuvant chemotherapy and fractionated stereotactic body radiotherapy correlates with pathologic response. Poster presentation at the Annual Meeting of the Gastrointestinal Cancers Symposium, January 19-21, 2012. San Francisco, CA.

29. Ly QP. Non-surgical Management of Breast Cancers. Department of Surgery Lectures;

University of Nebraska Medical Center; March 20, 2013. Omaha, NE.

Quan Ly, MD – CV (6/2019) Page 11

30. Ly QP. Primers for Translational Researchers. University of Nebraska Medical Center

SPORE Update; July 18, 2013. Omaha, NE.

31. Ly QP. Surgeon Burnout: A Disease or a Weakness. Department of Surgery Grand Rounds, University of Nebraska Medical Center; August 14, 2013. Omaha, NE.

32. Ly QP. Post-Surgical Anatomy. Department of Radiology Lectures; October 23, 2013.

Omaha, NE.

33. Tapia VJ, D'Souza GF, Qiu F, Nguyen G, Ly QP. Socioeconomic Status, Medical History, and Pathologic Findings in Breast Cancer Surgery Decisions. 11th Annual Academic Surgical Congress; February 4, 2016. Jacksonville, FL.

34. Klute KA, Lin C, Ly QP. Pancreatic Cancer: Advances in Detection and Treatment. The Ninth:

Extraordinary Innovations and Emerging Trends in Transplantation and Oncology from Nebraska Medicine, July 25, 2018, Omaha, NE.

INVITED SPEAKER

1. What I have learned after residency, Lankenau Medical Center Grand Rounds, Wynnewood,

PA. March 2006.

2. Surgical Management of GIST, 2nd Annual Fall Midwest Thoracic and Gastrointestinal

Oncology Conference, Omaha, NE. October 26, 2007.

3. Pancreatic Neuroendocrine Tumors, 3rd Annual Fall Midwest Thoracic and Gastrointestinal

Oncology Conference, Omaha, NE. November 4, 2008.

4. Gastric Cancers, Department of Surgery Grand Rounds, University of Nebraska Medical Center, Omaha, NE. February 18, 2009.

5. Establishment of new cell cultures, University of Nebraska Medical Center SPORE Retreat,

Nebraska City, NE. March 16, 2009.

6. Collagen I induced Epithelial to Mesenchymal Transition in Pancreatic cancers, University of

Nebraska Medical Center SPORE Retreat, Nebraska City, NE. March 16, 2009.

7. Surgical Management of Gastroesophageal Junction Tumors, 4th Annual Fall Midwest Thoracic

and Gastrointestinal Oncology Conference, Omaha, NE. September 29, 2009.

8. Surgical Management of Gastric Cancer, 5th Annual Fall Midwest Thoracic and

Gastrointestinal Oncology Conference, Omaha, NE. November 12, 2010.

9. Career Development Award: Establishing cell cultures from surgical specimens, University of

Nebraska Medical Center SPORE Retreat, Omaha, NE. December 6, 2010.

10. Novel Therapies for Pancreatic Cancer, Eppley Cancer Center Cancer Genes and Molecular

Regulation Program, University of Nebraska Medical Center, Omaha, NE. April 5, 2011.

Quan Ly, MD – CV (6/2019) Page 12

11. Clinical Physiology of Pancreatic Cancer, Section of Gastroenterology, University of Nebraska Medical Center, Omaha, NE. April 28, 2011.

12. Clinical Physiology of Pancreatic Cancer: An overview, Department of Surgery Grand Rounds,

University of Nebraska Medical Center, Omaha, NE. July 20, 2011.

13. Gastric Cancer: Surgeon view, Department of Surgery Lectures, University of Nebraska Medical Center, Omaha, NE. September 21, 2011.

14. Surgical Options in Palliation of Gastrointestinal Cancers, 6th Annual Fall Midwest Thoracic and

Gastrointestinal Oncology Conference, Omaha, NE. September 23, 2011.

15. Gastric Cancer: Overview, Section of Gastroenterology, University of Nebraska Medical Center, Omaha, NE. February 28, 2012.

16. Surgical Management of Colorectal Cancers, Department of Surgery Lectures, University of

Nebraska Medical Center, Omaha, NE. February 29, 2012.

17. Post-Surgical Anatomy, Department of Radiology Lectures, University of Nebraska Medical Center, Omaha, NE. May 8, 2012.

18. Total Mesorectal Resection, Department of Pathology Lectures, University of Nebraska

Medical Center, Omaha, NE. June 19, 2012.

19. Novel Therapies for Pancreatic Cancers, University of Nebraska Medical Center SPORE Retreat, Omaha, NE. July 30, 2012.

20. Cancer Surgery for Octogenarians, 7th Annual Fall Midwest Thoracic and Gastrointestinal

Oncology Conference, Omaha, NE. October 5, 2012.

21. Non-surgical Management of Breast Cancers, Department of Surgery Lectures, University of Nebraska Medical Center, Omaha, NE. March 20, 2013.

22. Primers for Translational Researchers, University of Nebraska Medical Center SPORE update,

Omaha, NE. July 18, 2013.

23. Surgeon Burnout: A Disease or a Weakness, Department of Surgery Grand Rounds, University of Nebraska Medical Center, Omaha, NE. August 14, 2013.

24. Update on GIST, 8th Annual Fall Midwest Thoracic and Gastrointestinal Oncology

Conference, Omaha, NE. October 4, 2013.

25. Post-Surgical Anatomy, Department of Radiology Lectures, University of Nebraska Medical Center, Omaha, NE. October 23, 2013.

26. Emerging Topics in Gastric Cancers: a Surgeon’s Perspective. 9th Annual Fall Midwest

Thoracic and Gastrointestinal Oncology Conference, Omaha, NE. October 3, 2014.

27. Neoadjuvant therapy for esophageal cancer: a Surgeon’s Perspective. 10th Annual Fall Midwest Thoracic and Gastrointestinal Oncology Conference, Omaha, NE. October 9, 2015.

Quan Ly, MD – CV (6/2019) Page 13

28. Pancreatic Cancer: Where are we now? Grand Rounds Department of Surgery, University of Nebraska Medical Center, Omaha, NE. January 13, 2016.

29. Multidisciplinary Panel Discussion with Audience Response System of Complex GI Cases. 11th

Annual Fall Midwest Thoracic and Gastrointestinal Oncology Conference, Omaha, NE. October 8, 2016.

30. Techniques for Esophagectomy-What have we learned? Cardiac and Thoracic Surgery Grand

Rounds, University of Nebraska Medical Center, Omaha, NE. October 26, 2016.

31. Pancreatic Cancer. CRGP 800-Principles and Methodologies of Cancer Research Course Lecture, University of Nebraska Medical Center, Omaha, NE. January 17, 2017.

32. Pathology and Surgeon’s Performance Quality. Pathology and Microbiology Clinical Grand

Rounds, University of Nebraska Medical Center, Omaha, NE. February 1, 2017.

33. Pancreatic, Esophageal, Gastric Cancer with Various Drains/Tubes. CL Werner Cancer Hospital Nursing Education Program, University of Nebraska Medical Center, Omaha, NE. May 9,

2017.

34. Pancreatic Adenocarcinoma: Multi-Disciplinary Approach. Cancer Diagnosis & Management: Collaborative Case Based Symposium, The Fred & Pamela Buffett Cancer Center, Omaha, NE. June 10, 2017.

35. Surgical Oncology Overview. CRGP 800-Principles and Methodologies of Cancer Research

Course Lecture, University of Nebraska Medical Center, Omaha, NE. October 16, 2017.

36. Gastric, Pancreatic, Esophageal Cancer with Various Drains/Tubes. Oncology Nurse Fellowship Program, University of Nebraska Medical Center, Omaha, NE. November 7, 2017.

37. Pancreatic Cancer: Where are we now? CRGP 800-Principles and Methodologies of Cancer

Research Course Lecture, University of Nebraska Medical Center, Omaha, NE. January 10, 2018.

38. Colon Cancer: What do you need to know? Lunch and Learn, First National Bank, Omaha, NE.

February 16, 2018.

39. IORT and OR Staff Presentation, University of Nebraska Medical Center, Omaha, NE. July 18,

2018.

40. Surgical Oncology. CRGP 910-Intensive Training in Translational Research, University of Nebraska Medical Center, Omaha, NE. September 5, 2018.

41. Abdominal Cancers. Oncology Nurse Fellowship Program, University of Nebraska Medical

Center, Omaha, NE. September 11, 2018.

42. Pancreatic Cancer. CRGP 800-Principles and Methodologies of Cancer Research Course Lecture, University of Nebraska Medical Center, Omaha, NE. January 9, 2019.

43. Research Committee Consensus Conference on Small HCC Management. Americas Hepato-

Pancreato-Biliary Annual Conference, Miami, FL. March 22, 2019.

Quan Ly, MD – CV (6/2019) Page 14

44. Upper GI Malignancies, Pancreatic, Esophageal, & Gastric Cancer with Various Drains and

Tubes. Oncology Nurse Fellowship Program, University of Nebraska Medical Center,

Omaha, NE. April 9, 2019.

45. Novel tumor specific T-cell expansion for the treatment of pancreatic ductal adenocarcincomas. Surgical Research Forum, University of Nebraska Medical Center, Omaha, NE. May 15,

2019.

46. Health Literacy for providers. Department of Pediatrics Grand Round, Children’s Hospital, Omaha, NE. September 7, 2019.

47. Health Literacy Gap. American College of Surgeons Annual Conference, San Francisco, CA.

October 30, 2019.

COMMUNITY SERVICE

April 2005 – October 2005 American Red Cross Volunteer September 2007 Supervised an American Medical Association Student Health Fair 2011 Alternate Delegate to the Nebraska Medical Association November & December 2011 Meeting with Nebraska state senators to discuss health care related

issues March 2011, 2018 & 2019 Participated in the Black Family Health and Wellness Health Fair September 2012 & 2013 Delegate to the Nebraska Medical Association

PUBLICATIONS

1. Kilcullen JK, Ly QP, Chang TH, Levenson SM, and Steinberg JJ. Nonviable Staphylococcus aureus and its peptidoglycan stimulate macrophage recruitment angiogenesis, fibroplasia, and collagen accumulation in wounded rats. Wound Repair Reg. March/April 1998. 6(2):149-156.

2. Krishnaswami S, Ly QP, Rothman VL, Tuszynski GP. Thrombospondin-1 Promotes Proliferative Healing Through Stabilization of PDGF. J Surg Res. September 2002.107 (1):124- 130.

3. Cox C, White L, Allred N, Meyers M, Dickson D, Dupont E, Cantor A, Ly Q, Dessureault S, King J,

Nicosia S, Vrcel V, Diaz N. Survival outcomes in node-negative breast cancer patients evaluated with complete axillary node dissection versus sentinel lymph node biopsy. Ann Surg Oncol. 2006. 13(5):708-711.

4. Curtis MW, Ly QP, Wheelock MJ, Johnson KR. Evidence that the V832M E-Cadherin Germ-Line

Missense Mutation Does Not Influence the Affinity of alpha-Catenin for the Cadherin/Catenin Complex. Cell Commun Adhes. 2007. 14(2):45-55.

5. Ly QP, Yeatman TJ. Clinical Relevance of the Targeted Interference with Src-Mediated Signal

Transduction Events. Recent Results Cancer Res. 2007. 172: 169-88.

6. Park JY, Helm JF, Zheng W, Ly QP, Hodul PJ, Centeno, BA, Malafa, MP. Silencing of the

candidate tumor suppressor gene solute carrier family 5 member 8 (SLC5A8) in human pancreatic cancer. Pancreas. 2008. 36(4): e32-9.

Quan Ly, MD – CV (6/2019) Page 15

7. Ly QP and Sasson AR. Modern surgical considerations for gastric cancer. J Natl Compr Canc Netw. 2008. 6(9): 885-894.

8. Bruzoni M, Parikh P, Celis R, Are C, Ly QP, Meza JL and Sasson AR. Management of the

primary tumor in patients with metastatic pancreatic neuroendocrine tumor: A contemporary single-institution review. Am J Surg. 2009;197(3): 376-381.

9. Sasson AR, Ly QP, Are C. Surgical quality: More than just margins and lymph nodes.

Gastrointest Cancer Res. 2009;3: 204-205.

10. Kiluk JV, Ly QP, Santillan AA, Meade T, Ramos D, Reintgen DS, Dessureault S, Davis M,

Shamehdi C, Cox CE. Erratum: Axillary Recurrence Rate Following Negative Sentinel Node Biopsy for Invasive Breast Cancer: Long-Term Follow-up. Ann Surg Oncol. 2010;17(2):552-557.

11. Melis M, Hernandez J, Siegel EM, McLoughlin JM, Ly QP, Nair RM, Lewis JM, Jensen EH,

Alvarado MD, Coppola D, Eschrich S, Bloom GC, Yeatman TJ, Shibata D. Gene expression profiling of colorectal mucinous adenocarcinomas. Dis Colon Rectum. 2010 Jun;53(6):936-943.

12. Dhir M, Smith LM, Ullrich F, Leiphrakpam PD, Ly QP, Sasson AR, Are C. Pre-operative

nomogram to predict risk of peri-operative mortality following liver resections for malignancy. J Gastrointest Surg. 2010 Nov;14(11):1770-1781.

13. Are C, Ly Q, Sasson AR. Primum non nocere, or leave that ostomy alone: Comment on

"Incisional hernias in temporary stoma wounds." Arch Surg. 2011 Jan;146(1):99-100.

14. Shah BC, Ullrich F, Smith L, Leiphrakpam P, Ly Q, Sasson A, Are C. National trends in

discharge disposition after hepatic resection for malignancy. HPB (Oxford). 2011 Feb;13(2):96-

102.

15. Lin C, Sasson AR, Ly QP, Kos ME, Schwarz JK, Are C, Chen S, Sehi ED, Enke CA, Grem JL. A

phase I study of hypofractionated stereotactic radiotherapy and concurrent HIV protease inhibitor, Nelfinavir, as part of a neoadjuvant regimen in patients with locally advanced pancreatic cancer.

Int J Radiat Onc. 2011 Vol. 81 (S68).

16. Dhir M, Smith LM, Ullrich F, Leiphrakpam PD, Ly QP, Sasson AR, Are C. A preoperative

nomogram to predict the risk of perioperative mortality following gastric resections for malignancy.

J Gastrointest Surg. 2012 Nov;16(11):2026-2036.

17. Lin C, Lazenby AJ, Hussain SM, Sasson AR, Chen S, Ly QP, Schwarz JK, Kos ME, Are C.

Borderline resectable pancreatic adenocarcinoma: Tumor volume and CA19-9 reduction following neoadjuvant chemotherapy and fractionated sterotactic body radiation therapy correlates with pathologic response. Int J Radiat Oncol. 2012 Nov;Vol. 84 (3): p. S320-321. 0360-3016.

18. Watley DC, Ly QP, Talmon G, Are C, Sasson AR. Clinical presentation and outcome of

nonfunctional pancreatic neuroendocrine tumors in a modern cohort. Am J Surg. 2015

Dec;210(6):1192-1196.

Quan Ly, MD – CV (6/2019) Page 16

19. Ajani JA, D'Amico TA, Almhanna K, Bentrem DJ, Chao J, Das P, Denlinger CS, Fanta P, Farjah F, Fuchs CS, Gerdes H, Gibson M, Glasgow RE, Hayman JA, Hochwald S, Hofstetter WL, Ilson DH, Jaroszewski D, Johung KL, Keswani RN, Kleinberg LR, Korn WM, Leong S, Linn C, Lockhart AC, Ly QP, Mulcahy MF, Orringer MB, Perry KA, Poultsides GA, Scott WJ, Strong VE, Washington MK, Weksler B, Willett CG, Wright CD, Zelman D, McMillian N, Sundar H. Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology. JCCN. 2016

Oct;14(10):1286-1312.

20. Verma V, Lazenby AJ, Zheng D, Bhirud AR, Ly QP, Are C, Sasson AR, Lin C. Dosimetric parameters correlate with duodenal histopathologic damage after stereotactic body radiotherapy for pancreatic cancer: Secondary analysis of a prospective clinical trial. Radiother Oncol. 2017 Mar;122(3):464-469.

21. Cathcart SJ, Sasson AR, Kozel JA, Oliveto JM, Ly QP. Duodenal gangliocytic paraganglioma with

lymph node metastases: A case report and comparative review of 31 cases. World J Clin Cases.2017 Jun 16; 5(6):222-233.

22. Shukla SK, Purohit V, Mehla K, Gunda V, Chaika NV, Vernucci E, King RJ, Abrego J, Goode GD,

Dasgupta A, Illies AL, Gebregiworgis T, Dai B, Augustine JJ, Murthy D, Attri KS, Mashadova O, Grandgenett PM, Powers R, Ly QP, Lazenby AJ, Grem JL, Yu F, Matés JM, Asara JM, Kim JW,

Hankins JH, Weekes C, Hollingsworth MA, Serkova NJ, Sasson AR, Fleming JB, Oliveto JM, Lyssiotis CA, Cantley LC, Berim L, Singh PK. MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer. Cancer

Cell. 2017 Jul 10;32(1):71-87.e7.

23. Shukla SK, Purohit V, Mehla K, Gunda V, Chaika NV, Vernucci E, King RJ, Abrego J, Goode GD, Dasgupta A, Illies AL, Gebregiworgis T, Dai B, Augustine JJ, Murthy D, Attri KS, Mashadova O, Grandgenett PM, Powers R, Ly QP, Lazenby AJ, Grem JL, Yu F, Matés JM, Asara JM, Kim JW, Hankins JH, Weekes C, Hollingsworth MA, Serkova NJ, Sasson AR, Fleming JB, Oliveto JM, Lyssiotis CA, Cantley LC, Berim L, Singh PK. Erratum: MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer.

Cancer Cell. 2017 Sep 11;32(3):392.

24. Van Buren G, Bloomston M, Schmidt CR, Behrman SW, Zyromski NJ, Ball CG, Morgan KA, Hughes SJ, Karanicolas PJ, Allendorf JD, Vollmer CM, Ly Q, Brown KM, Velanovich V, Winter JM, McElhany AL, Muscarella P, Schmidt CM, House MG, Dixon E, Dillhoff ME, Trevino JG, Hallet J, Coburn NSG, Nakeeb A, Behrns KE, Sasson AR, Ceppa EP, Abdel-Misih SRZ, Riall TS, Silberfein EJ, Ellison EC, Adams DB, Hsu C, Tran Cao HS, Mohammed S, Villafañe-Ferriol N, Barakat O, Massarweh NN, Chai C, Mendez-Reyes JE, Fang A, Jo E, Mo Q, Fisher WE. A Prospective Randomized Multicenter Trial of Distal Pancreatectomy With and Without Routine Intraperitoneal Drainage. Ann Surg. 2017 Sep; 266(3):421-431.

25. Mansour JC, Chavin K, Morris-Stiff G, Warner SG, Cardona K, Fong ZV, Maker A, Libutti SK, Warren R, St Hill C, Celinski S, Newell P, Ly QP, Howe J, Coburn N. Management of asymptomatic, well-differentiated PNETs. HPB (Oxford). 2018

26. Qi B, Crawford AJ, Wojtynek NE, Holmes MB, Souchek JJ, Almeida-Porada G, Ly QP, Cohen

SM, Hollingsworth MA, Mohs AM. Indocyanine green loaded hyaluronan-derived nanoparticles for fluorescence-enhanced surgical imaging of pancreatic cancer. Nanomedicine. 2018 April; 14(3):

769-780. Epub 2018 Jan 9.

Quan Ly, MD – CV (6/2019) Page 17

27. Olson MT, Ly QP, Mohs AM. Fluorescence Guidance in Surgical Oncology: Challenges, Opportunities, and Translation. Mol Imaging Biol. 1-19. 2018 Jun 25.

28. Mansour JC, Chavin K, Morris-Stiff G, Warner SG, Cardona K, Fong ZV, Maker A, Libutti SK,

Warren R, St Hill C, Celinski S, Newell P, Ly QP, Howe J, Coburn N. Management of asymptomatic, well-differentiated PNETs: results of the Delphi consensus process of the Americas Hepato-Pancreato-Biliary Association. HPB (Oxford). 2018 Dec 5.

29. Lin C; Verma V; Ly QP; Lazenby AJ; Sasson; AR, Schwarz JK; Meza JL; Are C; Li S; Wang S;

Hahn SM; Grem JL. Phase I trial of concurrent stereotactic body radiotherapy and nelfinavir for locally advanced borderline or unresectable pancreatic adenocarcinoma. Radiotherapy and Oncology. 132 : 55-62. 2019

BOOK CHAPTERS

1. Ly QP and Sondak V. “Essentials of Melanoma” Chapter 10 in Surgical Foundations: Essentials

of Surgical Oncology. M Sabel, J Sussman, V Sondak (Eds). 2007. Mosby Elsevier. P137-55. 2. Ly QP and Edney J. “Acute Colonic Obstruction” Chapter 28 in Common Problems in Acute

Care Surgery. LJ Moore, KL Turner and SR Todd (Eds). 2013. Springer. P353-358.

3. Are C, Ly Q, Sasson AR. “Hepatic Artery Infusional Chemotherapy for Colorectal Liver

Metastasis" in Liver Directed Therapy for Primary and Metastatic Liver Tumors. 2009. Springer.

EDITORIALS

1. Sasson AR, Ly QP, Are C. Surgical quality: more than just margins and lymph nodes.

Gastrointest Cancer Res. 2009;3(5): 204-5.

Ad Hoc Reviewer:

Annals of Surgery

Annals of Surgical Oncology

Journal of Surgical Research

ABSTRACTS

1. Ly Q, Ho G, Tate D, Klein S, Drouart A, Winiarsky R, Cajigas A, Romney S, Steinberg JJ. Immunocytochemical (cytokeratin and Ki-67) and DNA adduct analyses of human cervical lavage samples: preliminary biomarkers of chemoprevention. Proceedings of American Association for Cancer Research, March 1994. Vol 35, p. 621, Abstract# 3700.

2. Winiarsky R, Ly Q, Drouart A, Steinberg JJ, et al. Proliferation (BUDR & Ki-67) indices, and immunocytochemistry (vimentin) as biomarkers of therapeutic response by osteosarcoma cells. Proceedings of American Association for Cancer Research, March 1994. Vol 35, p. 240, Abstract# 1433.

3. Ly Q, Krishnaswami S, Rothman VL, Tuszynski GP. Thrombospondin-1 (TSP-1) Potentiates

Fibroblast Activities Important in Wound Healing. Proceedings of the American Society for Cell Biology, 1999.

Quan Ly, MD – CV (6/2019) Page 18

4. Ly Q, Cox C, White L, Dupont E, Cantor A, Reintgen DS, Dessureault S. Axillary recurrence after negative sentinel lymph node biopsy in breast cancer patients. Poster discussion at the 28th Annual San Antonio Breast Cancer Symposium, San Antonio, TX. December 9, 2005.

5. Ly Q, McCarthy S, Gruidl M, Yeatman, TJ. NBL1: A novel hypermethylation target in colon

cancer. Oral Presentation at the 59th Annual Meeting of the Society of Surgical Oncology,

San Diego, CA. March 25, 2006.

6. Ly Q, Siegel E, McLouglin J, Lewis J, Nair R, Jensen E, Alvarado M, Eschrich S, Yeatman TJ and Shibata D. NBL1 and Colon Cancer: Clinical and Genetic Associations. Poster presentation at the 60th Annual Meeting of the Society of Surgical Oncology, Washington, DC. March 17, 2007.

7. McLoughlin JM, Jensen EH, Alvarado M, Siegel E, Ly Q, Lewis JM, Nair RM, Eschrich S, Helm J,

Yeatman TJ and Shibata D. A Clinicogenomic Analysis of Right and Left-Sided Colon Cancers. Poster presentation at the 60th Annual Meeting of the Society of Surgical Oncology,

Washington, DC. March 17, 2007.

8. Meredith K, Siegel E, McLoughlin J, Nair R, Lewis J, Eschrich S, Bloom G, Ly Q, Jensen E, Alvarado M, Yeatman TJ and Shibata D. Clinicogenomic Characterization of Primary Colorectal Carcinoma Associated With Liver Metastases. Oral presentation at the 7th Annual Meeting of the AHPBA, Las Vegas, NV. April 22, 2007.

9. Meredith K, Siegel E, Sarnaik A, Alvarado M, Eschrich S, McLoughlin J, Nair R, Ly Q, Lewis J,

Jensen E, Yeatman TJ and Shibata D. Gene Expression Profiles and Recurrence in Stage II Colon Cancer. Plenary presentation at the Annual Meeting of the American Society of Colon and Rectal Surgeons, St. Louis, MO. June 4, 2007.

10. Melis M, Ly Q, Nair R, Siegel E, McLoughlin J, Lewis J, Jensen E, Alvarado M, Eschrich S, Bloom

G, Yeatman TJ and Shibata D. Colorectal Mucinous Adenocarcinomas Are Characterized By Markers of Differentiation and Components of the Mucin-Producing Machinery. Plenary presentation at the Annual Meeting of the American Society of Colon and Rectal Surgeons, St. Louis, MO. June 5, 2007.

11. Ly, QP. Establishment of Primary Cell Cultures from Surgically Resected Specimen. Presented

at University of Nebraska Medical Center Pancreatic SPORE Annual Retreat, Nebraska City,

NE. March 2009.

12. Shah B, Ullrich F, Leiphrakpam P, Ly Q, Sasson A, Are C. National trends in discharge disposition following hepatic resection for malignancy. International Hepato-Pancreato-Biliary Association, Argentina. 2010.

13. Vargas L, Kim E, Ly Q, Are C, Sasson A. Incidental pancreatic adenocarcinoma: Lack of

symptoms does not improve respectability rate. International Hepato-Pancreato-Biliary Association, Argentina. 2010.

14. Sasson A, Kim E, Ly Q, Are C. The benefit of intra-operative ultrasound in the management of

suspected gallbladder cancer. International Hepato-Pancreato-Biliary Association, Argentina. 2010.

Quan Ly, MD – CV (6/2019) Page 19

15. Sasson A*, Are C, Lazenby A, Ly Q. Comprehensive Pathologic Assessment of Pancreaticoduodenectomy Specimens. Poster presentation at the 63rd Annual Meeting of the Society of Surgical Oncology, St. Louis, MO. March 3-7, 2010.

16. Sasson A*, Are C, Ly Q. Role of Laparoscopy in Neo-Adjuvant Therapy for Pancreatic

Adenocarcinoma. Poster presentation at the 63rd Annual Meeting of the Society of Surgical Oncology, St. Louis, MO. March 3-7, 2010.

17. Lackner R, Trujillo K, Ly Q, Are C, Oleynikov D, Sasson A. Minimally invasive esophagectomy-

increasing the surgical options for esophageal cancer. Southwestern Surgical Congress,

Tucson, AZ. 2010.

18. Dhir M, Smith L, Ullrich F, Leiphrakpam P, Ly Q, Sasson A, Are C. Preoperative nomogram to predict risk of perioperative mortality following hepatic resection for malignancy. SSAT, New

Orleans, LA.2010.

19. Shah B, Smith L, Ullrich F, Ly Q, Sasson AR, Are C. National trends in discharge disposition following pancreatic resections for malignancy. Americas Hepato-Pancreato-Biliary Association, Miami, FL. 2011.

20. Malhotra G, Smith L, Ly Q, Sasson A, Are C. National trends in survival for pancreatic

adenocarcinoma based on location of the primary lesion. Plenary-Society of Surgery for Alimentary Tract, Chicago, IL. 2011.

21. Malhotra G, Smith L, Ly Q, Sasson A, Are C. National trends in the incidence and stage of

disease at initial presentation for patients with pancreatic adenocarcinoma. Society for Surgery of Alimentary Tract, Chicago, IL. 2011.

22. Dhir M, Smith L, Ullrich F, Ly Q, Sasson A, Are C. Pre-operative nomogram to predict risk of peri-

operative mortality following gastric resection for malignancy. Society for Surgery of Alimentary Tract, Chicago, IL. 2011.

23. Ly QP, Chaika N, Lele S, Lazenby A, Are C, Sasson A, Johnson K. In Pancreatic Cancer,

Metastatic Tissue Has Decreased hENT1 Expression Than Primary Tumor. Poster presentation at the 64th Annual meeting of the Society of Surgical Oncology, San Antonio, TX. March 2-5, 2011.

24. Ly QP, Wang W, Person J, et al. YM155, a small molecule inhibitor of survivin, as a novel

therapy in the treatment of pancreatic cancer. Oral presentation at the 7th Academic Surgical Congress, Las Vegas, NV. February 15, 2012.

25. Shah B, Smith LM, Sasson A, Ly Q, Are C. National trends in surgical management of cystic

lesions of the pancreas. 65th Annual Meeting of the Society of Surgical Oncology, Orlando,

FL. March 21-24, 2012.

26. Ly QP, Person J, Brattain MG. Survivin is a potential new therapeutic target in the treatment of pancreatic cancer. Poster presentation at the 65th Annual Meeting of the Society of Surgical Oncology, Orlando, FL. March 21-24, 2012.

Quan Ly, MD – CV (6/2019) Page 20

27. Lin C, Lazenby AJ, Hussain SM, Sasson AR, Chen S, Ly QP, Schwarz JK, Kos ME, Are C. Borderline Resectable Pancreatic Adenocarcinoma: Tumor Volume and CA19-9 Reduction Following Neoadjuvant Chemotherapy and Fractionated Stereotactic Body Radiotherapy Correlates with Pathologic Response. ASTRO Conference, Boston, MA. October 2012.

28. Ly QP, Howell G, Mendick M, Murari C, Laschanzky S, Brattain M. Survivin is a potential new

therapeutic target in the treatment of pancreatic cancer. APA Meeting, San Diego, CA.

November 2015.

29. Tapia VJ, D'Souza GF, Qiu F, Nguyen G, Ly QP. Socioeconomic Status, Medical History, and Pathologic Findings in Breast Cancer Surgery Decisions. 11th Annual Academic Surgical Congress, Jacksonville, FL. 2016.

30. Cole K, Ly Q, Cox J, Hollingsworth M, Padussis J, Foster J, Vargas L, Talmadge J. Novel

Expansion of CD8+PD1+ Spleen Cells for Therapeutic Intent In Pancreatic Adenocarcinoma Cancer Patients. NCI GI/Pancreatic SPOREs Meeting, Omaha, NE. October 29-30, 2018.

31. Enke T, Fingeret A, Are C, Vargas L, Foster J, Padussis J, Ly Q, Singh S, Shivaswamy V,

Boerner B. Immediate dysglycemia after pancreatic resection: Prevalence and risk factors. The Endocrine Society Annual Meeting, New Orleans, LA. March 23, 2019.

32. Cole K, Ly Q, Cox J, Hollingsworth M, Padussis J, Foster J, Vargas L, Talmadge J. Cellular

Phenotypes of Spleen cells in Cancer Patients targeted for Adoptive Cellular Therapy. AACR Annual Meeting, Atlanta, GA. March 29 – April 3, 2019.

33. Cole K, Britton H, Ly Q, Cox J, Hollingsworth M, Foster J, Vargas L, Padussis J, Talmadge J.

Novel Expansion of CD8+PD1+ Spleen Cells for Therapeutic Intent In Pancreatic Adenocarcinoma Cancer Patients. AACR Annual Meeting, Atlanta, GA. March 29 – April 3, 2019.

34. Talmadge J, Cole K, Ly Q, Hollingsworth M, Cox J. Frequency of Myeloid Derived Suppressor

Cells in Spleen and Peripheral Blood from Cancer Patients. American Association of Immunologists (AAI), San Diego, CA. May 2019.

LANGUAGES

English

Vietnamese